Home » Posts tagged with » Roche (Page 2)
Tecentriq wins FDA approval for extensive stage small cell lung cancer

Tecentriq FDA approval : Roche subsidiary Genetech has bagged a new approval from the US Food and Drug Administration (FDA) for Tecentriq (atezolizumab), this time in combination with chemotherapy as the first-line treatment of adult patients with extensive stage small cell lung cancer (ES-SCLC). The chemotherapy to be used for the indication alongside Tecentriq is […]

Continue reading …
Nordic Nanovector initiates Betalutin rituximab combo trial in 2L FL

Nordic Nanovector has announced the dosing of the first patient in a phase 1b clinical trial called Archer-1 for evaluating the combination of its investigational lymphoma drug Betalutin (177Lu-satetraxetan-lilotomab) with Roche cancer drug rituximab (RTX) as a second-line treatment for follicular lymphoma (2L FL). Rituximab is a CD20-targeting monoclonal antibody that is given as a […]

Continue reading …
Roche breast cancer drug combo cuts death rate and recurrence

Roche breast cancer drug, Perjeta (pertuzumab) in combination with Herceptin (trastuzumab) and chemotherapy has been demonstrated in a phase 3 trial to have cut the risk of disease recurrence besides increasing the life span of patients with an aggressive form of early breast cancer. Roche Breast Cancer Trial APHINITY Results The breast cancer drug combination which met […]

Continue reading …
Page 2 of 212